Nav: Home

The protective role of dengue immunity on Zika infection in a Brazilian favela

February 07, 2019

By monitoring the spread of Zika virus through a densely populated Brazilian favela during a 2015 outbreak, researchers have gained new perspectives into the outbreaks of this virus in the Americas in recent years. The results highlight the protective effect of prior immunity to dengue virus. Because many Zika virus (ZIKV) infections are asymptomatic and non-specific in their clinical presentation, the infection dynamics of the virus have been difficult to characterize. One key unknown, the subject of numerous studies, is the role of pre-existing immunity to dengue virus (DENV), an endemic pathogen that shares many similarities to ZIKV. While DENV immunity has been hypothesized to influence both susceptibility to and resistance of ZIKV infection, neither trajectory has been rigorously evaluated in human populations. Leveraging a long-term health study in Salvador, Brazil -- the epicenter of a 2015 ZIKV outbreak -- Isabel Rodriguez-Barraquer and colleagues were able to characterize the transmission of the virus within an urban favela community. Rodriguez-Barraquer et al. used multiple serological assays, collected before and after the 2015 outbreak. They revealed that, of the 1,435 community residents tested, nearly 73% were infected by ZIKV during the epidemic. The presence of pre-existing DENV antibodies was associated with less risk of ZIKV infection and also of fewer experienced symptoms among those infected with ZIKV. Rodriguez-Barraquer et al. emphasize the highly spatial nature of ZIKV attack rates, which could indicate pockets of susceptible individuals that could sustain virus transmission after an apparent end to an epidemic. According to the authors, these groups may represent an opportunity for vaccine trials, to truly and effectively resolve the epidemic in populations that appear to have high immunity.
-end-


American Association for the Advancement of Science

Related Dengue Virus Articles:

One step closer to a DNA vaccine against dengue virus
In a new study, researchers inoculated mice with a new DNA vaccine candidate (pVAX1-D1ME) in order to evaluate its efficiency.
8 in 10 Indonesian children has been infected with dengue
Indonesia has one of the highest burdens of dengue fever, a mosquito-borne virus, in the world, and children account for many cases.
A novel approach to seeing dengue infection in the body
Positron emission tomography (PET) paired with the glucose metabolism probe, fluorodeoxyglucose (FDG), is considered 'old' technology in the field of cancer.
Mosquitoes infected with virus-suppressing bacteria could help control dengue fever
Mosquitoes infected with the bacteria Wolbachia are significantly worse vectors for dengue virus, but how to establish and spread Wolbachia in an urban mosquito population is unclear.
Researchers identify tactic Dengue virus uses to delay triggering immune response
Mount Sinai researchers describe novel mechanism cells use to recognize earliest stages of infection and how virus evades triggering an immune response.
NUS scientists discover novel vulnerabilities in dengue virus
A team of researchers from the National University of Singapore has uncovered hidden vulnerabilities on the surface of the dengue virus.
Most dengue infections transmitted in and around home
Transmission of the mosquito-borne dengue virus appears to be largely driven by infections centered in and around the home, with the majority of cases related to one another occurring in people who live less than 200 meters apart, new research led by the Johns Hopkins Bloomberg School of Public Health and the University of Florida suggests.
Most dengue infections transmitted in or near home
The majority of dengue virus infections appear to happen very close to home and are transmitted from the same family of mosquitoes, suggests new research led by the University of Florida and the Johns Hopkins Bloomberg School of Public Health.
Pre-existing immunity to dengue virus shapes Zika-specific T cell response
Although Zika and dengue are considered different virus 'species,' they are so closely related that the immune system treats Zika just like another version of dengue, report researchers at La Jolla Institute for Allergy and Immunology.
Researchers create mosquito resistant to dengue virus
Researchers from the Johns Hopkins Bloomberg School of Public Health have genetically modified mosquitoes to resist infection from dengue virus, a virus that sickens an estimated 96 million people globally each year and kills more than 20,000, mostly children.

Related Dengue Virus Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Digital Manipulation
Technology has reshaped our lives in amazing ways. But at what cost? This hour, TED speakers reveal how what we see, read, believe — even how we vote — can be manipulated by the technology we use. Guests include journalist Carole Cadwalladr, consumer advocate Finn Myrstad, writer and marketing professor Scott Galloway, behavioral designer Nir Eyal, and computer graphics researcher Doug Roble.
Now Playing: Science for the People

#530 Why Aren't We Dead Yet?
We only notice our immune systems when they aren't working properly, or when they're under attack. How does our immune system understand what bits of us are us, and what bits are invading germs and viruses? How different are human immune systems from the immune systems of other creatures? And is the immune system so often the target of sketchy medical advice? Those questions and more, this week in our conversation with author Idan Ben-Barak about his book "Why Aren't We Dead Yet?: The Survivor’s Guide to the Immune System".